Max Wolf

The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia

Masa Lasica, Abbey Willcox, Kate Burbury, David M Ross, Susan Branford, Jason Butler, Robin Filshie, Henry Januszewicz, David Joske, Anthony Mills, David Simpson, Constantine Tam, Kerry Taylor, Anne-Marie Watson, Max Wolf, Andrew Grigg

Journal article  |  2019  |  Leukemia & Lymphoma

The management of CML in pregnancy is challenging with the need to balance disease control against potential teratogenic effects o..

Serial Minimal Residual Disease Evaluation in Patients with Chronic Lymphocytic Leukemia Under Long-Term Venetoclax Treatment

Thomas Lew, Mary Ann Anderson, Constantine S Tam, Sasanka Handunnetti, Dennis Carney, Max Wolf, Surender Juneja, David Alan Westerman, Andrew W Roberts, John F Seymour

Conference Proceedings  |  2018  |  Blood

Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy

Thomas E Lew, Chan Y Cheah, Dennis A Carney, H Miles Prince, Max Wolf, Ali Bazargan, E Henry Januszewicz, Robin Filshie, David Westerman, John F Seymour, Constantine S Tam

Journal article  |  2016  |  Leukemia & Lymphoma

The utility and limitations of F-18-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review

Chan Y Cheah, Michael S Hofman, John F Seymour, David S Ritchie, Michael Dickinson, Andrew Wirth, H Miles Prince, Max Wolf, Elchanan H Januszcewicz, Dennis A Carney, Kirsten E Herbert, Simon J Harrison, Kate L Burbury, Constantine S Tam

Journal article  |  2015  |  Leukemia & Lymphoma

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma

CY Cheah, KE Herbert, K O'Rourke, GA Kennedy, A George, PL Fedele, M Gilbertson, SY Tan, DS Ritchie, SS Opat, HM Prince, M Dickinson, K Burbury, M Wolf, EH Januszewicz, CS Tam, DA Westerman, DA Carney, SJ Harrison, JF Seymour

Journal article  |  2014  |  British Journal of Cancer

Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy

Chan Y Cheah, Michael Dickinson, Michael S Hofman, Anupkumar George, David S Ritchie, H Miles Prince, David Westerman, Simon J Harrison, Kate Burbury, Max Wolf, Henry Januszewicz, Kirsten E Herbert, Dennis A Carney, Constantine Tam, John F Seymour

Journal article  |  2014  |  ANNALS OF HEMATOLOGY

Prognostic impact of monocyte count at presentation in mantle cell lymphoma

Anupkumar George, Henry Miles Prince, Jeff Szer, Max Wolf, Elchanan H Januszewicz, John F Seymour, David S Ritchie

Journal article  |  2014  |  British Journal of Haematology

Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy

CY Cheah, MS Hofman, M Dickinson, A Wirth, D Westerman, SJ Harrison, K Burbury, M Wolf, H Januszewicz, K Herbert, HM Prince, DA Carney, DS Ritchie, RJ Hicks, JF Seymour

Journal article  |  2013  |  BRITISH JOURNAL OF CANCER

Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma

Nicole Wong Doo, Philip A Thompson, H Miles Prince, John F Seymour, David Ritchie, Kerrie Stokes, Kate Burbury, Max Wolf, Trish Joyce, Simon J Harrison

Journal article  |  2013  |  Leukemia and Lymphoma

Emergence of central nervous system myeloma in the era of novel agents

Shane A Gangatharan, Dennis A Carney, H Miles Prince, Max M Wolf, E Henry Januszewicz, David S Ritchie, Simon J Harrison

Journal article  |  2012  |  Hematological Oncology

Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group

Andrew Wirth, Andrew Grigg, Max Wolf, David Goldstein, Carol Johnson, Sidney Davis, Gaelle Dutu, Poppy Kypreos, Carole Smith, Andrew Kneebone, Mark Herzberg, David Joseph, John Catalano, Daniel Roos, Janey Stone, John Reynolds

Journal article  |  2011  |  Leukemia and Lymphoma

Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma

PA Thompson, HM Prince, JF Seymour, D Ritchie, K Stokes, K Burbury, M Wolf, S Peinert, T Joyce, SJ Harrison

Journal article  |  2011  |  Bone Marrow Transplantation

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy

DA Carney, DA Westerman, CS Tam, A Milner, HM Prince, M Kenealy, M Wolf, EH Januszewicz, D Ritchie, N Came, JF Seymour

Journal article  |  2010  |  Leukemia

Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenstrom macroglobulinemia

Stefan Peinert, Constantine S Tam, H Miles Prince, John Scarlett, Max M Wolf, E Henry Januszewicz, David Westerman, John F Seymour

Journal article  |  2010  |  Leukemia and Lymphoma

Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma

Andrew P Grigg, Janey Stone, Alvin D Milner, Anthony P Schwarer, Max Wolf, H Miles Prince, John Seymour, Devinder Gill, David Ellis, John Bashford

Journal article  |  2010  |  Leukemia and Lymphoma

Mantle cell lymphoma with central nervous system involvement: frequency and clinical features

Saar Gill, Kirsten E Herbert, H Miles Prince, Max M Wolf, Andrew Wirth, Gail Ryan, Dennis A Carney, David S Ritchie, John M Davies, John F Seymour

Journal article  |  2009  |  British Journal of Haematology

Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator

KE Herbert, S Morgan, HM Prince, DA Westerman, MM Wolf, DA Carney, K Yuen, J di Iulio, JF Seymour

Journal article  |  2009  |  Leukemia

Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set

MJ Bishton, RJ Hicks, HM Prince, DS Ritchie, M Wolf, JF Seymour

Journal article  |  2008  |  Leukemia

The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders

Mark N Polizzotto, Constantine S Tam, Aivin Milner, E Henry Januszewicz, H Miles Prince, David Westerman, Max M Wolf, John F Seymour

Journal article  |  2006  |  Cancer